EXPLORING THE MODIFIED GAMMA FRAILTY DISTRIBUTION: AN OPTIMAL DESIGN APPROACH USING PYTHON
DOI:
https://doi.org/10.33003/fjs-2023-0703-1970Keywords:
Frailty Models, Censorship, Survival Analysis, PythonAbstract
A suction/injection controlled mixed convection flow of an incompressible and viscous fluid in a vertical SurvivalAnalysis is pivotal in understanding the effects of covariates on potentially censored failure times and in the joint modelling of clustered data. It is used in the context of incomplete repeated measures and failure times in longitudinal studies. Survival data are often subject to right censoring and to a subsequent loss of information about the effect of explanatory variables. Frailty models are one common approach to handle such data.Three frailty models are used to analyze bivariate time-to-event data. All approaches accommodate right censored lifetime data and account for heterogeneity in the study population. A Modified Gamma Frailty Model is compared with two existing Frailty Models. The survival-analysis was performed using the Python.The newly derived MGF was analyzed using Python which is more robust when sample size is more than forty.The MGF model performs better than the existing models in the presence of clustering. However the CGF is preferable in the absence of clusters in a given data set.
References
Aggarwal, A. N., Agarwal, R., Dhooria, S., Prasad, K. T., Sehgal, I. S., and Muthu, V. (2022). Impact of COVID-19 pandemic on tuberculosis notifications in India. Lung India, 39(1) 89-91. Doi: 10.4103/lungindia.lungindia_604_21
Alagna, R., Besozzi, G., Codecasa, L. R., Gori, A., Migliori, G. B., Raviglione, M., and Cirillo, D. M. (2020). Celebrating World Tuberculosis Day at the time of COVID-19. European Respiratory Journal, 55(4) 1-3.
Ahmed N. and Hasnain, S. (2011). "Molecular Epidemiology of Tuberculosis in India: Moving forward with a systems biology approach". Tuberculosis 91 (5): 407–413.
Amiri, H., Mohammadi, M.J., Alavi, S.M., Salmannzadeh, S., Hematnia F., and Azar, M. (2021). Capture - recapture based study on the completeness of smear positive pulmonary tuberculosis reporting in southwest Iran during 2016. BMC Public Health 21, 2318 1-10. https://doi.org/10.1186/s12889-021-12398-w
Boffan, J., Mhlaba, T., Sulis, G., Moyo, S., Sifumba, Z., Pai, M., andDaftary, A. (2020). COVID-19 and tuberculosis in South Africa: A dangerous combination. SAMJ: South African medical journal, 110(5), 1-2.
Centres for Disease Control and Prevention (CDC, 2022). Effect of COVID-19 on Tuberculosis in the U.S. CDC online newsroom: Thursday, March 24, 2022.
Cilloni, L., Fu, H., Vesga, J. F., Dowdy, D., Pretorius, C., Ahmedov, S., Nair, S. A., Mosneaga, A., Masini, E., Sahu, S., and Arinaminpathy, N. (2020). The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine, 28, 100603.
Global Partnership for Zero Leprosy (GPZL, 2020). Working group assesses challenges and a path forward for leprosy during COVID-19. zeroleprosy.org
Madhukar, P., Tereza, K., and Soumya S. (2022). COVID-19’s Devastating Effect on Tuberculosis Care – A Path to Recovery. The new England journal of medicine; 386:1490-1493. doi: 10.1056/nejmp2118145
Izudi, J.,Tamwesigire, I. K. and Bajunirwe, F. (2020). Treatment success and mortality among adults with tuberculosis in rural eastern Uganda: a retrospective cohort study. BMC Public Health (2020) 20:501 https://doi.org/10.1186/s12889-020-08646-0
Jain, V. K., Iyengar, K. P., Samy, D. A., and Vaishya, R. (2020). Tuberculosis in the era of COVID-19 in India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 1439-1443.
John, S., Gidado, M., Dahiru, T., Fanning, A., Codlin, A. J., and Creswell, J. (2015). Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding. The International Journal of Tuberculosis and Lung Disease, 19(4), 463-468.
Kant, S. and Tyagi, R. (2021). The impact of COVID-19 on tuberculosis: challenges and opportunities. Therapeutic Advances in Infectious Diseases. doi: 10.1177/20499361211016973
Liu, Q., Lu, P., Shen, Y., Li, C., Wang, J., Zhu, L., Lu. W., and Martinez, L. (2021). Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China. Clinical Infectious Diseases. 73(3) 542-544. https://doi.org/10.1093/cid/ciaa1289
Louie, J. K., Reid, M., Stella, J., Agraz-Lara, R., Graves, S., Chen, L. and Hopewell, P. (2020). A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic. Int J Tuberc Lung Dis, 24(8), 860-2.
Nath, R., Gupta, N. K., Gupta, N., Tiwari, P., Kishore, J., and Ish, P. (2021). Effect of COVID-19 pandemic on tuberculosis notification. Indian J. Tuberc,doi: 10.1016/j.ijTb.2021.08.007 [Epub ahead of print]. Retrieved from https://www.ncbi.nih.gov/pmc/articles/PMC8358081/ on 6th June, 2022.
National Tuberculosis Leprosy Control Programme (NTLCP, (n. d)). https://www.leprosy-information.org/organization/ntblcp-national-tuberculosis-leprosy-control-programme.
Oshi, D. C., Omeje, J. C., Oshi, S. N., Alobu, I. N., Chukwu, N. E., Nwokocha, C., Emelumadu, C. L., Meka, A. o. and Ukwaja, K. N. (2017). An evaluation of innovative community-based approaches and systematic tuberculosis screening to improve tuberculosis case detection in Ebonyi state, Nigeria. International journal of mycobacteriology, 6(3), 246-252.
Soko, R. N., Burke, R. M., Feasey, H. R. A., Sibande, W., Nliwasa, M., Henrion, M. Y. R.,Khundi, M., Dodd, P. J., Ku, C. C., Kawalazira, G., Choko, A. T., Corbett, E. L., And MacPherson, P. (2021). Effects of Coronavirus Disease Pandemic on Tuberculosis Notification, Malawi. Emerging Infectious Diseases, 27(7), 1831-1839. Doi: 10.3201/eid2707.210557
Tadolini, M., García-García, J.-M., Blanc, F.-X., Borisov, S., Goletti, D., Motta, I., Codecasa, R, L., Tiberi, S., Sotgiu, G. and Migliori, G. B. (2020). On tuberculosis and COVID-19 co-infection. European Respiratory Journal, 56(2)2002328.
Togun, T., Kampmann, B., Stoker, N. G. and Lipman, M. (2020). Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Annals of clinical microbiology and antimicrobials, 19, 1-6.
Udwadia, Z. F., Vora, A., Tripathi, A. R., Malu, K. N., Lange, C., and Raju, R. S. (2020). COVID-19-Tuberculosis interactions: When dark forces collide. Indian Journal of Tuberculosis. 67(4S):S155-S162. doi: 10.1016/j.ijtb.2020.07.003.
Ukwaja, K. N., Alobu, I. and Hopewell, P. C. (2013). The high cost of free tuberculosis services: patient and household costs associated with tuberculosis care in Ebonyi State, Nigeria. PloS one, 8(8), e73134.
Ungvarski, P. J., and Flaskerud, J. H. (1999). HIV/AIDS: A guide to primary care management: Philadelphia: WB Saunders
Visca, D., Ong, C. W. M., Tiberi, S., Centis, R., D’Ambrosio, L., Chen, B., Mueller J., Duarte, R., Dalcolmo, M., Sotgiu. G., Migliori G.B. and Goletti, D. (2021). Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology. 27(2):151-165. doi: 10.1016/j.pulmoe.2020.12.012.
World Health Organization (2003). Treatment of tuberculosis: guidelines for national programmes. Geneva
World Health Organization Regional Office for Africa (2017). Framework for implementing the End TB in African Region 2016-2020https://apps.who.int/iris/bitstream/handle/10665/259636/TBstrat-eng.pdf?sequence=1#:~:text=It%20aims%20to%20end%20the,the%20TB%20epidemic%20by%202030.
World Health Organization (2021a). WHO consolidated guidelines on tuberculosis Module 2: Screening – Systematic screening for tuberculosis disease. https://www.who.int/publications/i/item/9789240022676
World Health Organization (2021b). Global tuberculosis report: TB Mortality. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021/disease-burden/mortality
Published
How to Cite
Issue
Section
FUDMA Journal of Sciences
